Focus: Sensome is a medical device company specializing in smart sensor technologies for interventional procedures in neurology and oncology. The company develops intelligent guidewire and diagnostic systems to enhance procedural precision and patient outcomes.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow Sensome to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Flagship product with dual indications in high-value interventional markets; currently undergoing clinical validation.
Help build intelligence for Sensome
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Sensome's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Oncology-focused diagnostic sensor system representing company's expansion into cancer care; early-stage clinical evidence.
No open positions listed yet. Check their careers page directly.
Recent peer-reviewed publications with author affiliations at this company
Identifying ex vivo acute ischemic stroke thrombus composition using electrochemical impedance spectroscopy.
C-reactive protein expression in acute ischemic stroke blood clots: Implications for etiology.
Showing 5 of 7 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo